Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schmid

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine|June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma RegisterSusanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2025
Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR CohortAnna von Bülow, Susanne Hansen, Patrik Sandin, et al.
Nature|November 14, 2003
Evolution of the polarization of the optical afterglow of the gamma-ray burst GRB030329Jochen Greiner, Sylvio Klose, Klaus Reinsch, et al.
The Science of the Total Environment|August 26, 2021
The coupled socio-ecohydrological evolution of river systems: Towards an integrative perspective of river systems in the 21st centuryThomas Hein, Christoph Hauer, Martin Schmid, et al.
European Clinical Respiratory Journal|January 9, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) studyJann Mortensen, Lars Kristensen, Mathias Munkholm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 8, 2026
Identifying an At-Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe DiseaseEmilie Johanning Bari, Susanne Hansen, Patrik Sandin, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine|June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma RegisterSusanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2025
Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR CohortAnna von Bülow, Susanne Hansen, Patrik Sandin, et al.
Nature|November 14, 2003
Evolution of the polarization of the optical afterglow of the gamma-ray burst GRB030329Jochen Greiner, Sylvio Klose, Klaus Reinsch, et al.
The Science of the Total Environment|August 26, 2021
The coupled socio-ecohydrological evolution of river systems: Towards an integrative perspective of river systems in the 21st centuryThomas Hein, Christoph Hauer, Martin Schmid, et al.
European Clinical Respiratory Journal|January 9, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) studyJann Mortensen, Lars Kristensen, Mathias Munkholm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 8, 2026
Identifying an At-Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe DiseaseEmilie Johanning Bari, Susanne Hansen, Patrik Sandin, et al.
Pageof 10